such as real estate has increased by over 10% year on year. In 2024, the number of companies with employee in the pharmaceuticals & biologics industry reached 84, with an opportunity emergence proportion of 38.36%, 2023. The number of such companies across industries reached 1,222 in 2024, with an opportunity emergence proportion of 47.87%. Employee health and safety opportunity emergence is reflected in a company's higher opportunities closely with their core industry characteristics: the former is R&D-intensive, so its training focuses on R&D technology and other contents; the latter, facing significant safety risks and urgent green transition needs, centres its training on safe operations and transition-related skills. The steady growth in companies with employee development and training helps atract and retain top talent, improving labour productivity and product